COVID-19 mRNA Vaccines Show Promising Results in Boosting Cancer Immunotherapy Effectiveness

Oct 23, 2025 08:27 am CST

Research reveals that COVID-19 mRNA vaccines may significantly improve survival rates in lung and skin cancer patients receiving immunotherapy, with vaccinated lung cancer patients nearly twice as likely to survive three years after treatment. Scientists are now exploring how mRNA technology could be specifically optimized for cancer treatment beyond its original purpose.